On Thursday shares of VIVUS Inc. (NASDAQ:VVUS) closed at $2.43. Company’s sales growth for last 5 years was 29.50% and EPS growth for next 5 years is recorded as 6.70%. On 30 March, VIVUS Inc. (NASDAQ:VVUS) announced an operational update, including certain key corporate decisions and plans regarding Qsymia® (phentermine and topiramate extended-release) capsules CIV. These plans include further investments in high-value, consumer-focused digital media projects in support of obesity education and Qsymia, and focusing the Qsymia field sales organization of approximately 100 territories on the most productive target areas.
OXiGENE, Inc. (NASDAQ:OXGN) in last trading activity moved down -1.37% to close at $1.44. Company weekly performance is 3.60% while its quarterly performance stands at -10.56%. OXiGENE, Inc. (NASDAQ:OXGN) is -63.27% away from its 52 week high. OXiGENE, Inc. (NASDAQ:OXGN) said that, it will participate in the 14th Annual Needham Healthcare Conference on April 15, 2015. The presentation will take place at 3:00 p.m. ET at The Westin NY Grand Central Hotel in New York, NY.
Zogenix, Inc. (NASDAQ:ZGNX) has 0.90% insider ownership while its institutional ownership stands at 64.70%. In last trading activity company’s stock closed at $1.47. On 26 March, Zogenix, Inc. (NASDAQ:ZGNX) announced that dosing has begun in patients enrolled in its Relday™ multi-dose Phase 1b clinical study. Relday is a proprietary, long-acting, subcutaneously injected formulation of risperidone being investigated for the treatment of schizophrenia.
On last trading day Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) moved down -3.31% to close at $6.14. Its volatility for the week is 3.02% while volatility for the month is 4.11%. HIMX’s sales growth for past 5 years was -1.50% and its EPS growth for past 5 years was -2.10%. Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) monthly performance is -18.78%. Bank of America downgraded shares of Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) from a buy rating to an underperform rating in a research note released on Tuesday morning.
On last trading day Chanticleer Holdings, Inc. (NASDAQ:HOTR) advanced 3.08% to close at $2.34. Its volatility for the week is 9.24% while volatility for the month is 11.07%. Chanticleer Holdings, Inc. (NASDAQ:HOTR) monthly performance is 7.34%. On 1 April, Chanticleer Holdings, Inc. (NASDAQ:HOTR) announced the release of its 2014 financial results for the fourth quarter (“Q4 2014”) and full year ended December 31, 2014 (the “YE 2014”). Total revenue for Q4 2014 was $8.64 million, compared with $3.31 million in the comparable period in 2013.